Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$754,959,577
+$272,341,631 QoQ
Shares Held
14,861,409
-9.2% QoQ
Ownership
3.75%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6.62173418415441.ToString("F0")%
Shared 0.02085939496046438.ToString("F0")%
None 93.35740642088513.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,293,175,602 across 421 Biotechnology names. MRNA ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $754,959,577 | 14,861,409 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $482,617,946 | 16,365,478 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $441,915,008 | 17,108,595 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $476,496,709 | 17,270,631 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $504,022,119 | 17,778,558 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $730,861,472 | 17,577,236 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,125,899,177 | 16,847,212 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,784,092,400 | 15,023,936 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,540,008,849 | 14,452,035 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,454,329,252 | 14,623,723 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,441,027,298 | 13,951,276 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,728,608,080 | 14,227,227 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,161,846,600 | 14,076,355 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,568,640,901 | 14,300,417 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,715,342,304 | 14,506,066 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $2,109,405,953 | 14,766,580 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,557,566,613 | 14,847,130 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,774,998,712 | 14,863,370 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,371,714,623 | 13,957,581 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,721,363,848 | 7,325,576 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $786,862,050 | 6,008,874 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $629,399,050 | 6,024,687 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $465,812,835 | 6,583,927 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $386,992,000 | 6,026,974 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $164,634,281 | 5,496,971 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||